Hi, what are you looking for?
– Yossi Abu: We have not yet fulfilled the entire potential of the Leviathan field. – – Please help us out : Will you...
– The digital ad company’s valuation for the IPO will reportedly be $400-500 million. – – As things stand at the moment, the first...
– According to IMS data Xeloda made by Genentech, had $754 million in US sales in 2013. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)...
– “Reuters” reports that the Italian energy giant is in talks to buy Noble and Delek’s stakes in the Karish and Tanin fields. –...
– Abravanel’s is the first senior departure from Teva since Erez Vigodman became CEO. – – In the first departure from the senior management...
– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)...
– Chairman and CEO Phillip Frost: From an R&D perspective, all our programs are progressing. – – – Opko Health Inc. (NYSE: OPK; TASE: OPK) reported higher...
– The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. –...
– Ron Lauder is investing in the Caesarea incubator through R&R Venture Partners. – – Ron Lauder is investing in the Nielsen Innovate incubator in Caesarea...
– Perrigo Company plc Announces Acquisition Of OTC Products In Australia – Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket...